HallPD, LesherBA, HallRK. Adjuvant therapy of node-negative breast cancer. Ann Pharmacother1995;29:289-98.
2.
VizosoF, SanchezLM, Diez-ItzaI, MerinoAM, Lopez-OtinC.Pepsinogen C is a new prognostic marker in primary breast cancer. J Clin Oncol1995;13:54-61.
3.
Sheen-ChenSM, ChouFF, EngHL, ChenWJ. An evaluation of the prognostic significance of HLA-DR expression in axillary node-negative breast cancer. Surgery1994;116:510-5.
4.
JanickeF, SchmittM, PacheL, UlmK, HarbeckN, HofterH. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treatment1993;24:195-208.
5.
DeschCE, HillnerBE, SmithTJ, RetchinSM. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes. J Clin Oncol1993;11:777-82.
